Exacerbation of Crohn's disease after insertion of a levonorgestrel intrauterine system: A case report

Journal of Family Planning and Reproductive Health Care

Volumn 29, Issue 3, 2003, Pages 154-

  Wakeman, Jacqueline G ^a  

^a St Chad Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ENTERITIS; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; PELVIC INFLAMMATORY DISEASE; RELAPSE; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT PLANNING; VAGINA BLEEDING;

EID: 0038037174     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118903101197548     Document Type: Article

References (5)

1. Kane S. Caring for women with inflammatory bowel disease. J Gend Specif Med 2001; 4: 54-59.
2. Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plann Reprod Health Care 2002; 28: 73-77.
3. Rubin GP, Hungin APS, Kelly PJ, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14: 1553-1559.
4. Clinical Alert. Smoking, use of oral contraceptives, and medical induction of remission were risk factors for relapse in Crohn's disease. Gut 1999; 44: 311-312.
5. Cosnes J, Carbonnel F, Carrat F, et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999; 45(2): 218-222.